Meet IAG’s Musculoskeletal Radiology Expert Team at OARSI’24
Dr. Olga Kubassova, and Prof. Mikael Boesen will be attending OARSI meeting in Vienna to meet researchers, drug developers and patients united by the goal of development of better treatment for osteoarthritis.
Dr. Kubassova, IAG’s President will be speaking during the Clinical Trial Symposium on the subject of ‘Imaging Modalities for Identification of the Molecular Inflammatory Endotype of Progressive OA’.
Her talk will cover IAG’s experience in working with pain and disease-modifying drug candidates, and how to deploy efficient imaging strategy to assess drugs efficacy.
Clinical Trials Symposium, Friday, April 19, 2024, 2:00 PM to 3:30 PM, Moderators: Morten Karsdal & Ali Mobasheri
- Current Evidence for Anti-inflammatory Treatments of OA as DMOADs
Richard Loeser, University of North Carolina - Imaging Modalities for Identification of the Molecular Inflammatory Endotype of Progressive OA
Olga Kubassova, Image Analysis Group - Soluble Biomarkers of Inflammation and Tissue Destruction: The Inflammatory Endotype
Anne-Christine Bay-Jensen, Nordic Bioscience
At IAG, we support our biotech and pharma partners developing novel pain targeting and disease-modifying osteoarthritis drugs. At OARSI, we will be presenting our latest work focused on improving the speed and accuracy of patient selection in clinical trials. Precise radiological review and A.I. in drug development improve the trial outcomes and help identifying populations that have the highest probability to respond to a particular treatment. IAG will also showcase its platfiorm DYNAMIKA for efficient and robust data collection, quality control and review.
Schedule a meeting with our expert team: imaging.experts@ia-grp.com
About OARSI
OARSI is the premier international organization for scientists and health care professionals focused on the prevention and treatment of osteoarthritis through the promotion and presentation of research, education and the worldwide dissemination of new knowledge. To find out more about this conference click here.
About Image Analysis Group (IAG)
Image Analysis Group, is a leading imaging Clinical Research Organization that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for a companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications. Our team helps to optimise imaging studies by leveraging our in-house radiology expertise in the design and execution of trials, and through our cutting-edge Dynamika™ platform, which allows for effective imaging data management and accelerated patient recruitment.
Learn more: www.ia-grp.com
Reach out: imaging.experts@ia-grp.com
Follow the Company: Linkedin